Latest Ophthalmology News

Page 4 of 4
Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.
Ada Torres
Ada Torres
31 Jan 2025
Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.
Victor Sage
Victor Sage
31 Jan 2025
Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.
Victor Sage
Victor Sage
29 Jan 2025
Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.
Ada Torres
Ada Torres
16 Jan 2025

Browse the archive

Full archive